Among the most misunderstood tools in professional-corporation planning is corporate-owned life insurance. Used strategically, it provides tax-sheltered growth, estate liquidity, and critical support for succession and purification. Mishandled, it can disqualify a corporation from the Lifetime Capital Gains Exemption (LCGE) and lead to punitive taxation. For pharmacists — whose corporations are both professional and highly regulated — corporate-owned insurance serves a dual purpose: it helps preserve QSBC status and funds tax-efficient estate and succession goals.
What corporate-owned insurance is
A corporate-owned policy is purchased and owned by your corporation (the PPC or, better, the Holdco), with the pharmacist-owner or a key individual as the insured life, premiums paid by the corporation with after-tax dollars, and the corporation or Holdco as the beneficiary. Its purposes are to fund taxes on death, to satisfy buy-sell obligations, and to fund shareholder redemptions. The policy's cash surrender value (CSV) grows tax-deferred inside the corporation, and the death benefit triggers a credit to the Capital Dividend Account (CDA), allowing a tax-free distribution to shareholders.
Why insurance location matters
Under the Income Tax Act, a corporation must hold at least 90% active assets to qualify as a QSBC at sale or death. If corporate-owned insurance is recorded as a passive investment inside the operating pharmacy corporation, its CSV may count as a non-active asset and taint QSBC status. The solution is simple and powerful: hold the insurance in a Holding Company (Holdco), not the operating PPC. Doing so keeps the PPC's assets "pure" and LCGE-eligible, lets the Holdco accumulate cash value and invest excess dividends, segregates insurance proceeds for family use or buy-sell obligations, and enables inter-corporate loans or collateral borrowing for liquidity. The practical rule from the book: never leave long-term insurance assets inside your operating pharmacy — transfer them to the Holdco before the corporation accumulates significant cash value. The purification process generally is covered in our pharmacy succession guide.
CDA, ACB, and CSV — the three acronyms
Three concepts govern how corporate-owned insurance is taxed. The Capital Dividend Account (CDA) is a notional account that allows tax-free shareholder distributions; on death it is credited by the death benefit minus the policy's adjusted cost basis. The adjusted cost basis (ACB) is the net cost of premiums less the net cost of pure insurance; it reduces the CDA credit at death. The cash surrender value (CSV) is the investment component accessible during life; it grows tax-deferred and can affect QSBC status if held in the PPC. A simple example shows the payoff: a $1,000,000 death benefit with an ACB of $150,000 at death produces an $850,000 CDA credit, and that $850,000 can be paid to shareholders tax-free through a capital dividend.
Funding the taxes that arise at death
On death, a pharmacist's estate faces two major taxes: the deemed disposition of shares (capital-gains tax on FMV) and corporate-level tax on retained earnings if the corporation winds up. Insurance provides the liquidity to cover these without a fire sale of assets. The integration steps are to estimate the projected estate-tax liability from the corporate valuation, purchase a policy in the corporation or Holdco equal to that liability, designate the corporation as beneficiary so proceeds fund a redemption or buyout on death, and credit the CDA to pay tax-free capital dividends to surviving shareholders or family.
Insurance and the estate freeze
Life insurance complements an estate freeze by funding the redemption of preferred shares at death. The pharmacist exchanges common shares for fixed-value preferred shares (the freeze) and issues growth shares to a family trust or children; the Holdco buys insurance on the pharmacist's life; on death the Holdco receives tax-free proceeds and pays dividends to redeem the preferred shares; and the estate receives cash instead of shares, avoiding double taxation. This lets the next generation inherit the business unencumbered while ensuring estate liquidity. Our estate freeze guide covers the freeze itself.
Borrowing against the policy
Corporate-owned policies often accumulate significant cash value that can be borrowed against without triggering immediate tax. Under a collateral-loan strategy, the corporation pledges the policy's CSV as collateral for a bank loan, and the proceeds fund business expansion, tax payments, or retirement income (via a shareholder loan). Loan interest may be deductible where funds are used for business or investment purposes. The advantages are immediate liquidity without surrendering the policy, continued tax-deferred growth of the CSV, and no effect on the CDA at death. The caution: documentation must support business-purpose borrowing, because personal loans against the CSV can lead to shareholder-benefit assessments.
Insurance, buy-sell agreements, and the family trust
Life insurance is the backbone of most buy-sell agreements between pharmacy partners. Under a cross-purchase structure, each shareholder owns insurance on the other's life — simpler where there are few shareholders. Under a corporate-owned (criss-cross) structure, the corporation owns policies on each shareholder, so the death benefit stays in the corporation and the CDA credit funds the redemption. A hybrid combines both. Detailed insurance terms — ownership, premium responsibility, CDA treatment, and buyout pricing — belong in the shareholders' agreement to prevent disputes. Where a family trust owns non-voting shares of the Holdco or PPC, the CDA credit flows to the Holdco, which declares a capital dividend to the trust tax-free, and the trustees then distribute funds to beneficiaries — enabling multigenerational transfer while preserving the LCGE eligibility of the remaining corporate assets.
Premium-funding choices and recordkeeping
Premiums can be paid in several ways depending on the goal: a single-premium or limited-pay policy (higher upfront cost, fully paid within 10–20 years, suited to pre-retirement certainty); annual renewable term (low initial cost that rises, suited to short-term buy-sell funding); participating or universal life (builds CSV, pays dividends, supports long-term corporate investment and borrowing); and split-dollar arrangements (the corporation and shareholder share premiums and benefits). Always involve a tax professional so the CRA does not recharacterize corporate premiums as shareholder benefits. The most common oversight is neglecting to record insurance ownership and CDA tracking in the corporate records — an omission that can cost hundreds of thousands in lost tax-free dividends. Keep copies of all policy statements, assignments, and collateral documents in the corporate minute book.
Insurance that purified a pharmacy
The book's case study follows a pharmacist whose $2.8 million corporation held $600,000 in marketable securities — tainting QSBC status — and who faced a projected estate-tax liability of $900,000. She incorporated a Holdco, transferred the passive investments and insurance policies from the PPC to the Holdco via a section 85 rollover, and purchased a $1.5 million corporate-owned universal life policy in the Holdco. On death the proceeds flow to the Holdco, creating a roughly $1.4 million CDA credit, and the Holdco pays a tax-free capital dividend to the estate for the preferred-share redemption. The PPC is purified and QSBC status restored, the LCGE is claimed on the sale (saving over $700,000 in tax), and the insurance proceeds cover the estate's liabilities and prevent a forced sale. Proper placement of life insurance transformed a compliance obstacle into a wealth-preservation asset.
Regulatory and ethical considerations
Pharmacy regulators do not directly govern insurance, but ethical practice still calls for transparency and fairness. Insurance arrangements should be disclosed to co-owners and family stakeholders; corporate funds should not be used for policies benefiting unrelated parties; premiums should be paid consistently to avoid a policy lapse and a disruption of the CDA; and copies of all policy statements, assignments, and collateral documents belong in the corporate minute book. Where partners co-own the pharmacy, the buy-sell mechanics funded by insurance should be transparent and the valuation formula clear, so that a death or departure does not become a dispute.
A corporate-owned insurance and purification checklist
The book reduces the strategy to a practical checklist worth revisiting annually: hold the insurance in the Holdco, not the PPC, to preserve QSBC status; maintain CDA and ACB tracking so tax-free dividends can be paid; integrate the policy with any estate freeze so it funds the share redemption; use collateral loans for liquidity rather than surrendering the policy; include the policy details (ownership, premium responsibility, CDA treatment, buyout pricing) in the shareholders' agreement; amend the trust deed to receive CDA distributions where a family trust is involved; conduct an annual policy review to confirm coverage and compliance; record the insurance in the corporate minute book; coordinate with the accountant on the CDA filing; and review the policy's placement before any sale or succession to avoid disqualification from the LCGE. The recurring lesson is that the value of corporate-owned insurance is realized only when the records keep pace with the policy.
Corporate-owned life insurance is far more than an afterthought in a pharmacist's tax plan — it is an instrument for liquidity, risk management, and purification. By locating the policy within the Holdco, coordinating it with an estate freeze, and maintaining meticulous records, a pharmacist creates a self-funding mechanism that protects both the family and the pharmacy's LCGE eligibility.
This guide draws on Dale Barrett's book "Tax-Wise Estate Planning for Pharmacists" (Barrett Publishing). It is general information about Canadian tax and estate-planning concepts, not legal, tax, or accounting advice; pharmacy ownership rules vary by province and by College, so confirm the current rules and obtain professional advice before acting.